Nisa Investment Advisors, LLC Roivant Sciences Ltd. Transaction History
Nisa Investment Advisors, LLC
- $19.6 Billion
- Q1 2025
A detailed history of Nisa Investment Advisors, LLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 2,083 shares of ROIV stock, worth $23,746. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,083
Previous 955
118.12%
Holding current value
$23,746
Previous $11,000
90.91%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding ROIV
# of Institutions
337Shares Held
495MCall Options Held
3.67MPut Options Held
754K-
Qvt Financial LP New York, NY65.8MShares$750 Million69.8% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X061.9MShares$705 Million5.69% of portfolio
-
Viking Global Investors LP46MShares$525 Million1.55% of portfolio
-
Vanguard Group Inc Valley Forge, PA40.8MShares$465 Million0.01% of portfolio
-
Morgan Stanley New York, NY35.9MShares$410 Million0.03% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.03B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...